| Characteristic . | Patients, No. (%)a . |
|---|---|
| Sex | |
| Male | 1450 (99) |
| Female | 15 (1) |
| Gender | |
| Cisgender man | 1447 (98.8) |
| Transgender woman | 3 (0.2) |
| Cisgender woman | 14 (0.9) |
| Transgender man | 1 (0.1) |
| Region of birth | |
| European Region | 880 (64.14) |
| Region of Americas | 466 (33.97) |
| African Region | 18 (1.31) |
| Eastern Mediterranean Region | 3 (0.22) |
| South-East Asia Region | 1 (0.07) |
| Western Pacific Region | 4 (0.29) |
| Region of residence | |
| European Region | 1449 (99.38) |
| Region of Americas | 8 (0.55) |
| African Region | 1 (0.07) |
| Suspected exposure | |
| Sexual | 1385 (94.1) |
| Occupational | 6 (0.4) |
| Other | 45 (3.1) |
| Unknown | 36 (2.4) |
| Characteristic . | Patients, No. (%)a . |
|---|---|
| Sex | |
| Male | 1450 (99) |
| Female | 15 (1) |
| Gender | |
| Cisgender man | 1447 (98.8) |
| Transgender woman | 3 (0.2) |
| Cisgender woman | 14 (0.9) |
| Transgender man | 1 (0.1) |
| Region of birth | |
| European Region | 880 (64.14) |
| Region of Americas | 466 (33.97) |
| African Region | 18 (1.31) |
| Eastern Mediterranean Region | 3 (0.22) |
| South-East Asia Region | 1 (0.07) |
| Western Pacific Region | 4 (0.29) |
| Region of residence | |
| European Region | 1449 (99.38) |
| Region of Americas | 8 (0.55) |
| African Region | 1 (0.07) |
| Suspected exposure | |
| Sexual | 1385 (94.1) |
| Occupational | 6 (0.4) |
| Other | 45 (3.1) |
| Unknown | 36 (2.4) |
aPercentages are based on cases with available data.
| Characteristic . | Patients, No. (%)a . |
|---|---|
| Sex | |
| Male | 1450 (99) |
| Female | 15 (1) |
| Gender | |
| Cisgender man | 1447 (98.8) |
| Transgender woman | 3 (0.2) |
| Cisgender woman | 14 (0.9) |
| Transgender man | 1 (0.1) |
| Region of birth | |
| European Region | 880 (64.14) |
| Region of Americas | 466 (33.97) |
| African Region | 18 (1.31) |
| Eastern Mediterranean Region | 3 (0.22) |
| South-East Asia Region | 1 (0.07) |
| Western Pacific Region | 4 (0.29) |
| Region of residence | |
| European Region | 1449 (99.38) |
| Region of Americas | 8 (0.55) |
| African Region | 1 (0.07) |
| Suspected exposure | |
| Sexual | 1385 (94.1) |
| Occupational | 6 (0.4) |
| Other | 45 (3.1) |
| Unknown | 36 (2.4) |
| Characteristic . | Patients, No. (%)a . |
|---|---|
| Sex | |
| Male | 1450 (99) |
| Female | 15 (1) |
| Gender | |
| Cisgender man | 1447 (98.8) |
| Transgender woman | 3 (0.2) |
| Cisgender woman | 14 (0.9) |
| Transgender man | 1 (0.1) |
| Region of birth | |
| European Region | 880 (64.14) |
| Region of Americas | 466 (33.97) |
| African Region | 18 (1.31) |
| Eastern Mediterranean Region | 3 (0.22) |
| South-East Asia Region | 1 (0.07) |
| Western Pacific Region | 4 (0.29) |
| Region of residence | |
| European Region | 1449 (99.38) |
| Region of Americas | 8 (0.55) |
| African Region | 1 (0.07) |
| Suspected exposure | |
| Sexual | 1385 (94.1) |
| Occupational | 6 (0.4) |
| Other | 45 (3.1) |
| Unknown | 36 (2.4) |
aPercentages are based on cases with available data.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
